14-day Premium Trial Subscription Try For FreeTry Free
$1.19
-0.0200 (-1.65%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.15 $1.67 Thursday, 2nd May 2024 APTO stock ended at $1.19. This is 1.65% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 1.89% from a day low at $1.19 to a day high of $1.21.
90 days $1.15 $2.20
52 weeks $0.360 $6.60

Historical Aptose Biosciences prices

Date Open High Low Close Volume
Jan 14, 2022 $1.33 $1.36 $1.29 $1.34 373 400
Jan 13, 2022 $1.37 $1.39 $1.33 $1.35 412 000
Jan 12, 2022 $1.41 $1.41 $1.33 $1.38 675 900
Jan 11, 2022 $1.37 $1.45 $1.37 $1.39 366 500
Jan 10, 2022 $1.40 $1.41 $1.30 $1.38 574 800
Jan 07, 2022 $1.34 $1.42 $1.32 $1.39 457 500
Jan 06, 2022 $1.35 $1.40 $1.32 $1.32 380 200
Jan 05, 2022 $1.51 $1.54 $1.33 $1.37 569 700
Jan 04, 2022 $1.49 $1.54 $1.43 $1.49 495 929
Jan 03, 2022 $1.40 $1.55 $1.37 $1.52 836 734
Dec 31, 2021 $1.41 $1.48 $1.35 $1.35 933 082
Dec 30, 2021 $1.38 $1.50 $1.36 $1.41 1 036 942
Dec 29, 2021 $1.38 $1.45 $1.30 $1.35 855 327
Dec 28, 2021 $1.43 $1.44 $1.35 $1.37 699 220
Dec 27, 2021 $1.44 $1.47 $1.43 $1.43 1 041 509
Dec 23, 2021 $1.49 $1.50 $1.45 $1.47 1 004 450
Dec 22, 2021 $1.49 $1.50 $1.43 $1.47 1 103 526
Dec 21, 2021 $1.47 $1.54 $1.46 $1.50 1 368 463
Dec 20, 2021 $1.38 $1.46 $1.33 $1.39 1 781 830
Dec 17, 2021 $1.45 $1.58 $1.39 $1.50 3 343 552
Dec 16, 2021 $1.22 $1.58 $1.19 $1.47 8 426 506
Dec 15, 2021 $1.11 $1.27 $1.09 $1.19 5 773 768
Dec 14, 2021 $1.35 $1.40 $1.08 $1.11 9 901 739
Dec 13, 2021 $1.95 $2.00 $1.87 $1.95 1 975 970
Dec 10, 2021 $2.08 $2.09 $1.98 $1.99 945 866
Click to get the best stock tips daily for free!

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT